{"product_id":"biostatistics-in-clinical-trials-hardback-9780471822110","title":"Biostatistics in Clinical Trials (Hardback) 9780471822110","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eBiostatistics in Clinical Trials\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cfont size=\"4\"\u003eCarol K. Redmond (Edited by), C Redmond (Author), Theodore Colton (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780471822110, Wiley\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 14 March 2001\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e528 pages\u003cbr\u003e25.3 x 19.3 x 3.7 cm, 1.266 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\"Every professional statistician should have this well written and well composed book in his\/her collection.\" (\u003ci\u003eJournal of Statistical Computation and Simulation\u003c\/i\u003e, September 2005)  \u003cp\u003e\"...strongly recommended as a reference for an overview of biostatistics in clinical trials...\" (\u003ci\u003eStatistical Methods in Medical Research\u003c\/i\u003e, Vol.12, No.4, 2003)\u003c\/p\u003e \u003cp\u003e\"highly informative and useful book\" (\u003ci\u003eJournal of Tropical Paediatrics\u003c\/i\u003e, February 2002)\u003c\/p\u003e \u003cp\u003e\"This highly informative and readable book is part of the Wiley Reference Series in Biostatistics. This book will be a useful tool for generating the required evidence and is a handy reference for the design, conduct, analysis and interpretation of clinical trials.\" (\u003ci\u003eJournal of Tropical Pediatricstrics\u003c\/i\u003e)\u003c\/p\u003e \u003cp\u003e\"...a valuable reference and an excellent resource to add to classroom and other teaching tools...\" (\u003ci\u003eOncology\u003c\/i\u003e, Vol.63, No.1, 2002) \u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\"Biostatistics in Clinical Trials\" gehört zur Reihe 'Wiley Reference Series in Biostatistics' und basiert auf der renommierten 'Encyclopedia of Biostatistics'. Dieser Band enthält 25% neues Material, umfassend aktualisierte Artikel und Verweise aus der Enzyklopädie sowie prägnante Definitionen und Einführungen in zahlreiche Grundlagen aus der aktuellen Literatur. Darüber hinaus wird eine Reihe neuer Themen behandelt, wie z.B. Bayesche Methoden, ethische Fragen und die Nutzen-Risiko-Bewertung. Durch umfangreiche Querverweise findet der Leser rasch Definitionen und verwandte Konzepte .\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eAdaptive and Dynamic Methods of Treatment Assignment.\u003cbr\u003e \u003cbr\u003e Antibacterial Agent Trials.\u003cbr\u003e \u003cbr\u003e Audit and Quality Control.\u003cbr\u003e \u003cbr\u003e Bayesian Methods.\u003cbr\u003e \u003cbr\u003e Benefit\/Risk Assessment.\u003cbr\u003e \u003cbr\u003e Binding or Masking.\u003cbr\u003e \u003cbr\u003e Clinical Significance Versus Statistical Significance.\u003cbr\u003e \u003cbr\u003e Clinical Trials, Overview.\u003cbr\u003e \u003cbr\u003e Cluster Randomization.\u003cbr\u003e \u003cbr\u003e Cochrane Collaboration.\u003cbr\u003e \u003cbr\u003e Community Intervention Trials.\u003cbr\u003e \u003cbr\u003e Compliance Assessment.\u003cbr\u003e \u003cbr\u003e CONSORT.\u003cbr\u003e \u003cbr\u003e Controlled Clinical Trials.\u003cbr\u003e \u003cbr\u003e Cooperative Cancer Trials.\u003cbr\u003e \u003cbr\u003e Cooperative Heart Disease Trials.\u003cbr\u003e \u003cbr\u003e Cooperative Studies Program, US Department of Veterans Affairs.\u003cbr\u003e \u003cbr\u003e Cost-effectiveness.\u003cbr\u003e \u003cbr\u003e Covariate Imbalance, Adjustment for.\u003cbr\u003e \u003cbr\u003e Crossover Designs.\u003cbr\u003e \u003cbr\u003e Data and Safety Monitoring.\u003cbr\u003e \u003cbr\u003e Data and Safety Monitoring Boards.\u003cbr\u003e \u003cbr\u003e Data Management and Coordination.\u003cbr\u003e \u003cbr\u003e Drug Approval and Regulation.\u003cbr\u003e \u003cbr\u003e Drug Interactions.\u003cbr\u003e \u003cbr\u003e Eligibility and Exclusion Criteria.\u003cbr\u003e \u003cbr\u003e Equivalence Trials.\u003cbr\u003e \u003cbr\u003e Ethics.\u003cbr\u003e \u003cbr\u003e European Federation of Statisticians in the Pharmaceutical Industry (EFPSI).\u003cbr\u003e \u003cbr\u003e European Organization for Research and Treatment of Cancer (EORTC).\u003cbr\u003e \u003cbr\u003e Factorial Designs.\u003cbr\u003e \u003cbr\u003e Fraud.\u003cbr\u003e \u003cbr\u003e Group-randomization Designs.\u003cbr\u003e \u003cbr\u003e Guidelines.\u003cbr\u003e \u003cbr\u003e Historical Controls, Bias From.\u003cbr\u003e \u003cbr\u003e History, Early Cancer and Heart Disease Trials.\u003cbr\u003e \u003cbr\u003e History, Overview.\u003cbr\u003e \u003cbr\u003e Intention-to-Treat Analysis.\u003cbr\u003e \u003cbr\u003e International Studies of Infarct Survival (ISIS).\u003cbr\u003e \u003cbr\u003e Medical Ethics and Statistics.\u003cbr\u003e \u003cbr\u003e Medical Research Council (MRC) Streptomycin Trial.\u003cbr\u003e \u003cbr\u003e Meta-analysis.\u003cbr\u003e \u003cbr\u003e Missing Data.\u003cbr\u003e \u003cbr\u003e Multicenter Trials.\u003cbr\u003e \u003cbr\u003e Multiple Endpoints.\u003cbr\u003e \u003cbr\u003e Multiplicity.\u003cbr\u003e \u003cbr\u003e Noncompliance, Adjustment for.\u003cbr\u003e \u003cbr\u003e Nonrandomized Trials.\u003cbr\u003e \u003cbr\u003e NSABP and Advances in the Treatment of Breast Cancer.\u003cbr\u003e \u003cbr\u003e Number Needed to Treat (NNT).\u003cbr\u003e \u003cbr\u003e Outcome Measures.\u003cbr\u003e \u003cbr\u003e Pharmaceutical Industry, Statistics in.\u003cbr\u003e \u003cbr\u003e Phase I Trials.\u003cbr\u003e \u003cbr\u003e Phase II Trials.\u003cbr\u003e \u003cbr\u003e Physicians' Health Study.\u003cbr\u003e \u003cbr\u003e Postmarketing Surveillance of New Drugs and Assessment of Risk.\u003cbr\u003e \u003cbr\u003e Preclinical Treatment Evaluation.\u003cbr\u003e \u003cbr\u003e Prevention Trials.\u003cbr\u003e \u003cbr\u003e Protocols.\u003cbr\u003e \u003cbr\u003e QUOROM.\u003cbr\u003e \u003cbr\u003e Randomization.\u003cbr\u003e \u003cbr\u003e Randomized Treatment Assignment.\u003cbr\u003e \u003cbr\u003e Salk Vaccine.\u003cbr\u003e \u003cbr\u003e Sample Size Determination.\u003cbr\u003e \u003cbr\u003e Screening Trials.\u003cbr\u003e \u003cbr\u003e Sequential Methods.\u003cbr\u003e \u003cbr\u003e Society for Clinical Trials.\u003cbr\u003e \u003cbr\u003e Software.\u003cbr\u003e \u003cbr\u003e Statistical Review for Medical Journals.\u003cbr\u003e \u003cbr\u003e Statistical Review for Medical Journals, Guidelines for Authors.\u003cbr\u003e \u003cbr\u003e Statisticians in the Pharmaceutical Industry (PSI).\u003cbr\u003e \u003cbr\u003e Surrogate Endpoints.\u003cbr\u003e \u003cbr\u003e Textbooks.\u003cbr\u003e \u003cbr\u003e Time-varying Treatment Effect.\u003cbr\u003e \u003cbr\u003e Treatment--Covariate Interaction.\u003cbr\u003e \u003cbr\u003e University Group Diabetes Program (UGDP).\u003cbr\u003e \u003cbr\u003e Vaccine Studies.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Mathematics [\u003ca title=\"See our other books on Mathematics\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Mathematics%20%5BPB%5D%22\"\u003ePB\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Wiley","offers":[{"title":"Brand New","offer_id":52298059219224,"sku":"9780471822110","price":415.39,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/files\/9780471822110.jpg?v=1781733483","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/biostatistics-in-clinical-trials-hardback-9780471822110","provider":"Freshly Printed Books","version":"1.0","type":"link"}